U.S. stocks had a rough start this Tuesday, kicking off what is historically a difficult month for markets. Leading the decline were tech stocks, particularly Nvidia (NVDA), as chip stocks suffered a selloff. With traders already on edge, bracing for economic data and a key jobs report later this...

Enter NanoViricides, Inc. (NYSE American: NNVC), a company at the forefront of developing groundbreaking solutions to combat viral infections. With its lead drug candidate, NV-387, NNVC offers a potential life-saving approach to address the MPOX outbreak.

The Federal Reserve's preferred inflation gauge, the core Personal Consumption Expenditures (PCE) index, has given us more clarity on the inflationary environment as the Fed heads into its much anticipated September meeting.

Stocks are taking a positive turn despite Nvidia's mixed results, which stirred questions about the AI boom's sustainability. Meanwhile, strong economic data continued to support market sentiment.

Howard Hughes Holdings has recently captured significant attention as a potential take-private target, particularly by its largest shareholder, Pershing Square, which holds a 38% stake in the company.

The Federal Reserve’s recent announcement is an exciting and significant shift in monetary policy, with Fed Chair Jerome Powell stating that the time has finally come for the central bank to begin lowering interest rates.

Nvidia's upcoming earnings report is set to be a pivotal moment for the AI industry as well as the broader market. As the undisputed king in AI chip design and software, Nvidia's performance will likely set the tone for the sector and influence investor sentiment.